Delivery Order SPE2DR25D2012-SPE2DR26F1BHX
Award Date 11/5/25
Potential Completion Date 11/6/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,962.90 to AmerisourceBergen Drug Corp for Shingrix vial kits on November 5, 2025, with completion expected by November 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits on July 16, 2025, with completion targeted for July 17, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,783.60 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a...
- The Defense Logistics Agency awarded a delivery order valued at $5,695.90 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 25, 2025, with completion targeted for August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine administered to prevent herpes zoster (shingles) and is a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,206.70 to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of March 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster (shingles) and is a critical immunization product for military and veteran...
- The Defense Logistics Agency awarded a $11,028.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for SHINGRIX vial kits, with an ultimate completion date of October 27, 2025. This non-set-aside competitive award was issued on October 24, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. SHINGRIX is a recombinant zoster (shingles) vaccine indicated for the prevention of herpes zoster and related complications in adults age 50 and older,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $5,514.35, with an ultimate completion date of November 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a standard...
- The Defense Logistics Agency (DLA) awarded a $5,695.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of September 26, 2025. This non-set-aside contract was competitively awarded on September 25, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster and its complications in adult populations,...
- The Defense Logistics Agency awarded a delivery order valued at $10,533.22 to AmerisourceBergen Drug Corp for Shingrix vial kits on September 11, 2025, with completion scheduled for September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for prevention of herpes zoster (shingles) and post-herpetic neuralgia in...